BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29946183)

  • 1. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
    Krings G; Chen YY
    Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
    Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
    Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.
    Avigdor BE; Beierl K; Gocke CD; Zabransky DJ; Cravero K; Kyker-Snowman K; Button B; Chu D; Croessmann S; Cochran RL; Connolly RM; Park BH; Wheelan SJ; Cimino-Mathews A
    Clin Cancer Res; 2017 Aug; 23(16):4875-4884. PubMed ID: 28424200
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.
    Schwartz CJ; Ruiz J; Bean GR; Sirohi D; Joseph NM; Hosfield EM; Jacobs TW; Mukhtar RA; Chen YY; Krings G
    Mod Pathol; 2023 May; 36(5):100125. PubMed ID: 36870308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
    Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
    World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.
    Djomehri SI; Gonzalez ME; da Veiga Leprevost F; Tekula SR; Chang HY; White MJ; Cimino-Mathews A; Burman B; Basrur V; Argani P; Nesvizhskii AI; Kleer CG
    Nat Commun; 2020 Apr; 11(1):1723. PubMed ID: 32265444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes.
    McQuerry JA; Jenkins DF; Yost SE; Zhang Y; Schmolze D; Johnson WE; Yuan Y; Bild AH
    BMC Cancer; 2019 Sep; 19(1):881. PubMed ID: 31488082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-producing metaplastic breast carcinoma - a rare tumor with heterologous elements.
    Shruti S; Siraj F
    Ger Med Sci; 2017; 15():Doc17. PubMed ID: 29255401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.
    Sun X; Zuo K; Yao Q; Zhou S; Shui R; Xu X; Bi R; Yu B; Cheng Y; Tu X; Lu H; Yang W
    Mod Pathol; 2020 Dec; 33(12):2473-2482. PubMed ID: 32504034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaplastic breast carcinoma: pathology and clinical outcome.
    Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
    Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metaplastic breast cancer with a unique presentation and complete response to chemotherapy: a case report.
    Nahhat F; Doyya M; Zabad K; Ksiri H
    BMC Womens Health; 2024 May; 24(1):285. PubMed ID: 38734591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer.
    Hu J; Lang R; Zhao W; Jia Y; Tong Z; Shi Y
    Breast Cancer Res Treat; 2023 Jul; 200(1):23-36. PubMed ID: 37160814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin 5 expression in metaplastic breast carcinomas.
    Carpenter PM; Wang-Rodriguez J; Chan OT; Wilczynski SP
    Am J Surg Pathol; 2008 Mar; 32(3):345-53. PubMed ID: 18300817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
    Webersinke G; Burghofer J; Malli T; Rammer M; Jahn SW; Niendorf A; Tavassoli FA; Moinfar F
    Arch Pathol Lab Med; 2023 Dec; 147(12):1451-1457. PubMed ID: 36897999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma.
    Lien HC; Hsu CL; Lu YS; Chen TW; Chen IC; Li YC; Huang CS; Cheng AL; Lin CH
    Breast Cancer Res; 2023 Jan; 25(1):11. PubMed ID: 36707876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
    Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
    Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.
    Joneja U; Vranic S; Swensen J; Feldman R; Chen W; Kimbrough J; Xiao N; Reddy S; Palazzo J; Gatalica Z
    J Clin Pathol; 2017 Mar; 70(3):255-259. PubMed ID: 27531819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.